Cargando…

Leprosy treatment: Can we replace opinions with research?

Detalles Bibliográficos
Autor principal:	Scollard, David M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Viewpoints
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7544021/ https://www.ncbi.nlm.nih.gov/pubmed/33031407 http://dx.doi.org/10.1371/journal.pntd.0008636

Ejemplares similares

Treatment and Evaluation Advances in Leprosy Neuropathy
por: Ebenezer, Gigi J., et al.
Publicado: (2021)

COVID-19, leprosy, and neutrophils
por: Schmitz, Veronica, et al.
Publicado: (2021)

Unfinished business - Leprosy still not defeated
por: Scollard, David M.
Publicado: (2019)

Why machine learning (ML) has failed physical activity research and how we can improve
por: Fuller, Daniel, et al.
Publicado: (2022)

How much diagnostic safety can we afford, and how should we decide? A health economics perspective
por: Newman-Toker, David E, et al.
Publicado: (2013)

The Missing Millions: A Threat to the Elimination of Leprosy
por: Smith, William Cairns, et al.
Publicado: (2015)

Treatment of Aortic Stenosis in Elderly Individuals in Brazil: How Long Can We Wait?
por: Lopes, Marcelo Antônio Cartaxo Queiroga, et al.
Publicado: (2020)

Will cases of leprosy reaction increase with COVID-19 infection?
por: Antunes, Douglas Eulálio, et al.
Publicado: (2020)

Can the Augmented Web-based Applicant Experience Replace an Audition Rotation?
por: Goldman, Joshua J., et al.
Publicado: (2020)

High yield of retrospective active case finding for leprosy in Comoros
por: Ortuño-Gutiérrez, Nimer, et al.
Publicado: (2022)

What can we learn from neonates with COVID-19?
por: Xiao, Tian-Tian, et al.
Publicado: (2020)

Leprosy postexposure prophylaxis with single-dose rifampicin: Nepalese dermatologist’s dilemma
por: Parajuli, Niraj, et al.
Publicado: (2021)

Three drugs are unnecessary for treating paucibacillary leprosy—A critique of the WHO guidelines
por: Lockwood, Diana N. J., et al.
Publicado: (2019)

Response to “Three drugs are unnecessary for treating paucibacillary leprosy—A critique of the WHO guidelines”
por: Kumar, Bhushan, et al.
Publicado: (2020)

Inequities towards leprosy-affected people: A challenge during COVID-19 pandemic
por: Mahato, Sharika, et al.
Publicado: (2020)

Elusive variants in autosomal recessive disease: how can we improve timely diagnosis?
por: Horton, Ari E., et al.
Publicado: (2023)

Ethical Considerations of Unsolicited Medical Opinion in Movement Disorders
por: Araújo, Rui, et al.
Publicado: (2023)

Can we really teach cognitive behavioral therapy with a massive open online course?
por: Gargot, Thomas, et al.
Publicado: (2020)

Emergence from General Anaesthesia: Can We Discriminate between Emergence Delirium and Postoperative Pain?
por: Somaini, Marta, et al.
Publicado: (2023)

How Can Research Keep Up With eHealth? Ten Strategies for Increasing the Timeliness and Usefulness of eHealth Research
por: Baker, Timothy B, et al.
Publicado: (2014)

Using V̇o(2max) as a marker of training status in athletes—can we do better?
por: Podlogar, Tim, et al.
Publicado: (2022)

An innovative approach to screening and chemoprophylaxis among contacts of leprosy patients in low endemic settings: experiences from Cambodia
por: Cavaliero, Arielle, et al.
Publicado: (2019)

Initiatives to address leprosy as a human rights issue through the mandate of UN Special Rapporteur: Achievements and challenges
por: Nanri, Takahiro
Publicado: (2022)

Why do we need international standards on responsible research publication for authors and editors?
por: Wager, Elizabeth, et al.
Publicado: (2013)

How Can Research on Artificial Empathy Be Enhanced by Applying Deepfakes?
por: Yang, Hsuan-Chia, et al.
Publicado: (2022)

Strengthening global commitment to eliminating cervical cancer: What lessons from the past can we apply to the future?
por: Taghavi, Katayoun, et al.
Publicado: (2020)

The Zoom View: How Does Video Conferencing Affect What Our Patients See in Themselves, and How Can We Do Right by Them?
por: Daar, David A., et al.
Publicado: (2021)

The Challenges of Mitochondrial Replacement
por: Chinnery, Patrick F., et al.
Publicado: (2014)

Primary Multidrug-Resistant Leprosy, United States
por: Williams, Diana Lynn, et al.
Publicado: (2013)

What can we learn from HIV, COVID‐19 and mpox stigma to guide stigma‐informed pandemic preparedness?
por: Logie, Carmen H.
Publicado: (2022)

What cannabis can learn from Covid: Hydroxychloroquine research suggests the next step for medical cannabis research
por: Caputi, Theodore L.
Publicado: (2021)

Where Do We Go From Here? Defining an Agenda for Home-Based Records Research and Action Considering the 2018 WHO Guidelines
por: Brown, David W., et al.
Publicado: (2019)

COVID-19: Why Declining Biodiversity Puts Us at Greater Risk for Emerging Infectious Diseases, and What We Can Do
por: Khetan, Aditya K.
Publicado: (2020)

Last Word on Viewpoint: Using V̇o(2max) as a marker of training status in athletes–can we do better?
por: Podlogar, Tim, et al.
Publicado: (2022)

Buprenorphine-based opioid substitution therapy in India: A few observations, thoughts, and opinions
por: Ghosh, Abhishek, et al.
Publicado: (2018)

Self-reported physical activity before a COVID-19 ‘lockdown’: is it just a matter of opinion?
por: Cross, Troy J, et al.
Publicado: (2021)

First-line Advanced Cutaneous Melanoma Treatments: Where Do We Stand?
por: Abdulkarim, Louay S, et al.
Publicado: (2021)

Why Are We Not There Yet?
por: Wenger, Nanette K.
Publicado: (2021)

Personalized medicine and hospitalization for heart failure: if we understand it, we may be successful in treating it
por: Ahmad, Faheem A., et al.
Publicado: (2019)

Are We Sure We Fully Understand What an Infodemic Is? A Global Perspective on Infodemiological Problems
por: Rovetta, Alessandro, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j7d1ncp75sii7o6rg3n52rr8tn